Guardant Health's Reveal Blood Test Validated for Chemotherapy Monitoring Effectiveness

Guardant Health's Guardant Reveal blood test has been validated in a new study as an effective tool for monitoring chemotherapy response in patients with advanced solid tumors. The test detects changes in cancer over time, offering oncologists a timely and non-invasive tool for monitoring treatment. Results show that a decrease in tumor fraction signal after chemotherapy initiation is associated with longer treatment duration and increased survival rates.